Associate Director, Patient Safety Scientist

At Bristol Myers Squibb, our employees often ask, “Who are you working for?” - a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

Key partner and strategic advisor to Medical Safety Assessment Physician (MSAP)/Safety Management Team (SMT) Chair to characterize conditions for safe use of BMS medicines and proactively communicate safety evidence to influence decision‑making for assets in development and marketed products by evaluating and mitigating risks. Independently performs core signal detection activities and elevates program or portfolio issues impacting key SMT programs, priorities, resources, and milestones.

Leads safety data review meetings (SDRMs). Ensures pharmacovigilance regulatory compliance.

• Drives core signal detection and assessment activities, in partnership with the SMT Chair, throughout product life cycle (including review of safety‑related literature and quantitative signal detection). Demonstrates strong capability in using a wide range of tools/data sources to assess safety concerns, enabling informed decision‑making and proactive risk management.
• Leads SDRMs by reviewing and evaluating clinical data to support signal detection. Appropriately escalates issues impacting key SMT activities, milestones, and documents to the SMT Chair, demonstrating sound judgment and strategic awareness.
• Drives the strategy and execution for signal evaluation (e.g., case‑series, literature review, health authority/claims databases), promotes cross‑functional collaboration, authors comprehensive signal reports with clear preliminary conclusions, and ensures timely tracking, stakeholder engagement, and documentation within the signal management system.
• Executes strategy and provides strong medical writing for safety and risk management sections of aggregate safety documents (eg, DSUR, PBRER, PADER).
• Executes strategy, analyzes data, and writes ad hoc responses to health authorities (including supporting local markets in responding to risk management‑related queries from local HAs), and mentors less experienced scientists in this area.

• Leads the preparation, review, and strategic input for safety sections in key clinical trial documents, such as protocols, clinical study reports (CSR), investigator brochures (IB) including reference safety information (RSI), informed consent forms (ICF), and contraception language.
• Represents Patient Safety and supports safety strategy preparation at internal and external meetings (pre‑submission, Advisory Committees, Scientific Advice, data monitoring committee, publications, etc.).

• Executes on the safety strategy for regulatory filings, including contributing to safety strategy, key safety messages, and risk management approaches. Reviews and authors safety sections of marketing authorization applications (MAA), including safety table shells, Integrated Summary of Safety (ISS), Summary of Clinical Safety (SCS), clinical overview, briefing book, and initial product labeling (USPI, CCDS, SmPC). Authors responses to ad hoc regulatory safety requests (eg, 120‑day safety updates), proactively sourcing and interpreting safety data to evaluate the impact of emerging…